Analyst Information
Edward TenthoffSr Research Analyst![]() Ted Tenthoff is a managing director and senior research analyst at Piper Sandler, focused on the drug discovery sector of the biotech industry. In April 2013 and 2015, Tenthoff moderated panels at the International Adult Stem Cell Conference at the Vatican. He was ranked No. 2 stock picker in biotechnology by the 2012 Wall Street Journal "Best on the Street" survey and was ranked No. 1 stock picker for the life science tools and services sector in the 2006 Starmine Analyst Awards. Prior to joining Piper Sandler in 2003, he covered the genomics sector at Robertson Stephens & Company, and was a medical technology analyst at Lehman Brothers. Tenthoff received a bachelor’s degree in international relations from the University of Pennsylvania. |
Universe Coverage: Healthcare: Biotechnology | |
AGLE | Aeglea Biotherapeutics, Inc. |
ALNY | Alnylam Pharmaceuticals, Inc. |
ALPN | Alpine Immune Sciences, Inc. |
APVO | Aptevo Therapeutics Inc. |
ARAV | Aravive, Inc. |
ARGX | argenx SE |
ARWR | Arrowhead Pharmaceuticals |
ARVN | Arvinas Inc. |
ASLN | Aslan Pharmaceuticals Ltd. |
BCYC | Bicycle Therapeutics Ltd. |
CCXI | ChemoCentryx, Inc. |
CHMA | Chiasma, Inc. |
CRSP | CRISPR Therapeutics AG |
CYTK | Cytokinetics, Incorporated |
DYN | Dyne Therapeutics, Inc. |
ELOX | Eloxx Pharmaceuticals, Inc. |
EXEL | Exelixis, Inc. |
FATE | Fate Therapeutics, Inc. |
FULC | Fulcrum Therapeutics, Inc. |
GMDA | Gamida Cell Ltd. |
IGMS | IGM Biosciences, Inc. |
INFI | Infinity Pharmaceuticals, Inc. |
KLDO | Kaleido Biosciences, Inc. |
KDS NA | Kiadis Pharma NV |
KYMR | Kymera Therapeutics, Inc. |
MIST | Milestone Pharmaceuticals, Inc. |
MRNA | Moderna, Inc. |
NXTC | NextCure, Inc. |
OPK | OPKO Health, Inc. |
PRTC | PureTech Health Plc |
MCRB | Seres Therapeutics, Inc. |
STRO | Sutro Biopharma, Inc. |
SYBX | Synlogic, Inc. |
SYRS | Syros Pharmaceuticals, Inc. |
VRTX | Vertex Pharmaceuticals Inc. |
XNCR | Xencor, Inc. |
YMTX | Yumanity Therapeutics Inc. |